期刊文献+

溶血和脂血对血浆中抗凝蛋白及纤溶系统的影响 被引量:6

The effect of hemolysis and lipemia on anticoagulation protein activity and fibrinolytic system in plasma
下载PDF
导出
摘要 目的探讨标本溶血和脂血对血浆中抗凝蛋白和纤溶系统的影响。方法用真空采血管抽取50例住院患者空腹静脉血各两管,无黄疸、脂血、溶血,即刻以3 000r/min离心10min,立即测定抗凝血酶Ⅲ(ATⅢ)、蛋白C(PC)、蛋白S(PS)、D-二聚体(D-Dimer)、纤维蛋白降解产物(FDP)水平,作为对照组。然后每管分装3份,同时制备不同水平溶血和脂血标本,分别测定上述抗凝和纤溶指标,与对照组结果进行比较。结果不同程度溶血标本与对照组相比,轻、中度溶血患者5种指标水平差异无统计学意义(P>0.05);重度溶血组ATⅢ活性显著升高(P<0.05),PC活性显著降低(P<0.05),而PS活性、D-Dimer、FDP水平差异无统计学意义(P>0.05)。不同程度脂血标本与对照组相比,轻、中度脂血患者5种指标水平差异无统计学意义(P>0.05);重度脂血组ATⅢ活性显著降低(P<0.05),PC和PS活性、D-Dimer、FDP水平显著升高(P<0.05)。结论为保证抗凝蛋白活性和纤溶系统水平,应严格控制分析前质量控制。 Objective To investigate the influence of hemolysis and lipemia on anticoagulation protein activity and fibrinolytic system in plasma.Methods Blood from 50inpatients by vacutainer were collected,without jaundice,lipemia and hemolysis.And the blood was centrifuged at 3 000r/min for 10minutes,which were selected as control group.AntithrombinⅢ(ATⅢ),protein C(PC),protein S(PS),D-Dimer,fibrin degradation product(FDP)level were detected.Then the left plasma were divided into three grades(mild,moderate and severe hemolysis)based on the level of hemoglobin,the concentrations of ATⅢ,PC,PS,D-Dimer,FDP were detected three times.The another left plasma were divided into three levels(mild,moderate and severe lipemia)based on the level of triglycerides,and the levels of ATⅢ,PC,PS,D-Dimer and FDP after adding the fat emulsion were determined.The results were statistically analyzed.Results There were statistically significances of ATⅢand PC between control group and severe hemolytic group(P<0.05).There were no significances for PS,D-Dimer,FDP between control group and mild,moderate hemolytic group(P>0.05).There were statistically significances for ATⅢ,PC,PS,D-Dimer and FDP between control group and severe lipemia group(P<0.05).But there was no significance of the indicators between mild and moderate lipemia group(P>0.05).ATⅢof severe lipemia had decreased significantly,while PC,PS,D-Dimer and FDP had increased significantly(P<0.05).Conclusion In order to guarantee the activity of anticoagulant protein and the level of fibrinolysis system,quality control before analysis should be strictly controlled.
作者 李蕾 王培昌 LI Lei;WANG Peichang(Department of Clinical Laboratory,Capital Medical University Xuanwu Hospital,Beijing100053,China)
出处 《检验医学与临床》 CAS 2019年第6期790-792,共3页 Laboratory Medicine and Clinic
关键词 抗凝血酶Ⅲ 蛋白C 蛋白S D-二聚体 纤维蛋白降解产物 antithrombinⅢ protein C protein S D-Dimer fibrinogen degradation product
  • 相关文献

参考文献9

二级参考文献52

  • 1林向华,曾华,王惠英,梁穆兴.保存温度和时间对凝血标本APTT和PT结果的影响[J].现代医院,2007,7(3):68-69. 被引量:6
  • 2丛玉隆.关于卫生部出凝血时间操作规程《通告》的理解[A]..全国血栓与止血学术研讨会专家讲义[C].中华医学会检验分会中华检验医学杂志编辑委员会,2001,8.73~80.
  • 3罗春丽.临床检验基础[M].北京:人民卫生出版社,2004:98-99.
  • 4蘆田克已.木兒マヅン濁度數[J].檢查じ技衍,1992,20:1125-1127.
  • 5中甫.干涉物質の影響じァの試檢法[J].QAP NEWS,1989,39:2-8.
  • 6NCCLS. Interference Testing in Clinical Chemistry [J].Proposed Guideline, 1986,6: 332-335.
  • 7丛玉隆 王淑娟.今日临床检验学[M].北京:中国科学技术出版社,1998.73-74.
  • 8National committee for clinical laboratory standards.Interference testing in clinical chemistry.Propose guideline[S].EP7,Pennsylvania:NCCLS,1986:6.
  • 9Lippi G, Guidi GC, Mattiuzzi C, et al. Preanalytieal variability : the dark side of the moon in laboratory testing. Clin Chem Lab Med, 2006,44 : 358-365.
  • 10Lippi G, Favaloro E J, Salvagno GL, et al. Laboratory assessment and perioperative management of patients on antiplatelet therapy: from the bench to the bedside. Clin Chim Acta, 2009, 405:8-16.

共引文献78

同被引文献59

引证文献6

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部